"Designing Growth Strategies is in our DNA"

Human Insulin Market Size, Share & COVID-19 Impact Analysis, By Type (Analogue Insulin And Traditional Human Insulin), By Diabetes Type (Diabetes 1 And Diabetes 2), By Distribution Channel (Hospital Pharmacy And Retail & Online Pharmacy), and Regional Forecast, 2022-2029

Region : Global | Format: PDF | Report ID: FBI100395

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Pipeline Analysis, Key Players
    2. Pricing Analysis, Key Countries, 2021
    3. Prevalence of Diabetes, For Key Countries, 2021
    4. Brand Analysis – By Key Countries
    5. Key Market Strategies, By Key Players
    6. Overview of Regulatory Scenario – For Key Countries/ Regions
    7. Impact of COVID-19 on the Market
  5. Global Human Insulin Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Analogue Insulin
        1. Long-acting
        2. Fast-acting
        3. Premix
      2. Traditional Human Insulin
        1. Long-acting
        2. Short-acting
        3. Fast-acting
        4. Premix
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Diabetes 1
      2. Diabetes 2
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Human Insulin Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Analogue Insulin
        1. Long-acting
        2. Fast-acting
        3. Premix
      2. Traditional Human Insulin
        1. Long-acting
        2. Short-acting
        3. Fast-acting
        4. Premix
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Diabetes 1
      2. Diabetes 2
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Diabetes Type
      2. Canada
        1. By Diabetes Type
  7. Europe Human Insulin Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Analogue Insulin
        1. Long-acting
        2. Fast-acting
        3. Premix
      2. Traditional Human Insulin
        1. Long-acting
        2. Short-acting
        3. Fast-acting
        4. Premix
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Diabetes 1
      2. Diabetes 2
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
        1. By Diabetes Type
      2. Germany
        1. By Diabetes Type
      3. France
        1. By Diabetes Type
      4. Italy
        1. By Diabetes Type
      5. Spain
        1. By Diabetes Type
      6. Scandinavia
        1. By Diabetes Type
      7. Rest of Europe
        1. By Diabetes Type
  8. Asia Pacific Human Insulin Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Analogue Insulin
        1. Long-acting
        2. Fast-acting
        3. Premix
      2. Traditional Human Insulin
        1. Long-acting
        2. Short-acting
        3. Fast-acting
        4. Premix
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Diabetes 1
      2. Diabetes 2
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. China
        1. By Diabetes Type
      2. Japan
        1. By Diabetes Type
      3. India
        1. By Diabetes Type
      4. Australia
        1. By Diabetes Type
      5. Southeast Asia
        1. By Diabetes Type
      6. Rest of Asia Pacific
        1. By Diabetes Type
  9. Latin America Human Insulin Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Analogue Insulin
        1. Long-acting
        2. Fast-acting
        3. Premix
      2. Traditional Human Insulin
        1. Long-acting
        2. Short-acting
        3. Fast-acting
        4. Premix
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Diabetes 1
      2. Diabetes 2
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
        1. By Diabetes Type
      2. Mexico
        1. By Diabetes Type
      3. Rest of Latin America
        1. By Diabetes Type
  10. Middle East & Africa Human Insulin Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Analogue Insulin
        1. Long-acting
        2. Fast-acting
        3. Premix
      2. Traditional Human Insulin
        1. Long-acting
        2. Short-acting
        3. Fast-acting
        4. Premix
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Diabetes 1
      2. Diabetes 2
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC
        1. By Diabetes Type
      2. South Africa
        1. By Diabetes Type
      3. Rest of Middle East & Africa
        1. By Diabetes Type
  11. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, SWOT Analysis, Recent Developments, Strategies, financials (based on availability))
      1. Novo Nordisk A/S
        1. Overview,
        2. SWOT Analysis,
        3. Recent Developments,
        4. Strategies,
        5. financials (based on availability)
      2. Eli Lilly and Company
        1. Overview,
        2. SWOT Analysis,
        3. Recent Developments,
        4. Strategies,
        5. financials (based on availability)
      3. Sanofi
        1. Overview,
        2. SWOT Analysis,
        3. Recent Developments,
        4. Strategies,
        5. financials (based on availability)
      4. BIOTON S.A.
        1. Overview,
        2. SWOT Analysis,
        3. Recent Developments,
        4. Strategies,
        5. financials (based on availability)
      5. Gan & Lee Pharmaceuticals Co Ltd.
        1. Overview,
        2. SWOT Analysis,
        3. Recent Developments,
        4. Strategies,
        5. financials (based on availability)
      6. Biocon
        1. Overview,
        2. SWOT Analysis,
        3. Recent Developments,
        4. Strategies,
        5. financials (based on availability)
      7. Tonghua Dongbao Pharmaceutical Co., Ltd.
        1. Overview,
        2. SWOT Analysis,
        3. Recent Developments,
        4. Strategies,
        5. financials (based on availability)
      8. Julphar
        1. Overview,
        2. SWOT Analysis,
        3. Recent Developments,
        4. Strategies,
        5. financials (based on availability)
      9. WOCKHARDT
        1. Overview,
        2. SWOT Analysis,
        3. Recent Developments,
        4. Strategies,
        5. financials (based on availability)
Read Less

Figure 01: Global Human Insulin Market Revenue Breakdown (USD billion, %) by Region, 2021 & 2029

Figure 02: Global Human Insulin Market Value Share (%), By Type, 2021 & 2029

Figure 03: Global Human Insulin Market Value Share (%), By Diabetes Type, 2021 & 2029

Figure 03: Global Human Insulin Market Value Share (%), By Distribution Channel, 2021 & 2029

Figure 04: Global Human Insulin Market Value Share (%), By Region, 2021 & 2029

Figure 06: North America Human Insulin Market Value (USD billion), by Type, 2021 & 2029

Figure 07: North America Human Insulin Market Value Share (%), by Type, 2021

Figure 08: North America Human Insulin Market Value (USD billion), by Diabetes Type, 2021 & 2029

Figure 09: North America Human Insulin Market Value Share (%), by Diabetes Type, 2021

Figure 10: North America Human Insulin Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 11: North America Human Insulin Market Value Share (%), by Distribution Channel, 2021

Figure 12: North America Human Insulin Market Value (USD billion), by Country, 2021 & 2029

Figure 13: North America Human Insulin Market Value Share (%), by Country, 2021

Figure 14: Europe Human Insulin Market Value (USD billion), by Type, 2021 & 2029

Figure 15: Europe Human Insulin Market Value Share (%), by Type, 2021

Figure 16: Europe Human Insulin Market Value (USD billion), by Diabetes Type, 2021 & 2029

Figure 17: Europe Human Insulin Market Value Share (%), by Diabetes Type, 2021

Figure 18: Europe Human Insulin Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 19: Europe Human Insulin Market Value Share (%), by Distribution Channel, 2021

Figure 20: Europe Human Insulin Market Value (USD billion), by Country/ Sub-region, 2021 & 2029

Figure 21: Europe Human Insulin Market Value Share (%), by Country/ Sub-region, 2021

Figure 22: Asia Pacific Human Insulin Market Value (USD billion), by Type, 2021 & 2029

Figure 23: Asia Pacific Human Insulin Market Value Share (%), by Type, 2021

Figure 24: Asia Pacific Human Insulin Market Value (USD billion), by Diabetes Type, 2021 & 2029

Figure 25: Asia Pacific Human Insulin Market Value Share (%), by Diabetes Type, 2021

Figure 26: Asia Pacific Human Insulin Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 27: Asia Pacific Human Insulin Market Value Share (%), by Distribution Channel, 2021

Figure 28: Asia Pacific Human Insulin Market Value (USD billion), by Country/ Sub-region, 2021 & 2029

Figure 29: Asia Pacific Human Insulin Market Value Share (%), by Country/ Sub-region, 2021

Figure 30: Latin America Human Insulin Market Value (USD billion), by Type, 2021 & 2029

Figure 31: Latin America Human Insulin Market Value Share (%), by Type, 2021

Figure 32: Latin America Human Insulin Market Value (USD billion), by Diabetes Type, 2021 & 2029

Figure 33: Latin America Human Insulin Market Value Share (%), by Diabetes Type, 2021

Figure 34: Latin America Human Insulin Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 35: Latin America Human Insulin Market Value Share (%), by Distribution Channel, 2021

Figure 36: Latin America Human Insulin Market Value (USD billion), by Country/ Sub-region, 2021 & 2029

Figure 37: Latin America Human Insulin Market Value Share (%), by Country/ Sub-region, 2021

Figure 38: Middle East and Africa Human Insulin Market Value (USD billion), by Type, 2021 & 2029

Figure 39: Middle East and Africa Human Insulin Market Value Share (%), by Type, 2021

Figure 40: Middle East and Africa Human Insulin Market Value (USD billion), by Diabetes Type, 2021 & 2029

Figure 41: Middle East and Africa Human Insulin Market Value Share (%), by Diabetes Type, 2021

Figure 42: Middle East and Africa Human Insulin Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 43: Middle East and Africa Human Insulin Market Value Share (%), by Distribution Channel, 2021

Figure 44: Middle East and Africa Human Insulin Market Value (USD billion), by Country/ Sub-region, 2021 & 2029

Figure 45: Middle East and Africa Human Insulin Market Value Share (%), by Country/ Sub-region, 2021

Figure 46: Global Human Insulin Market Share (%), 2021 

Table 01: Global Human Insulin Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 02: Global Human Insulin Market Revenue (USD billion) Forecast, By Analogue Insulin, 2018–2029

Table 03: Global Human Insulin Market Revenue (USD billion) Forecast, By Traditional Human Insulin, 2018–2029

Table 04: Global Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 05: Global Human Insulin Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 06: Global Human Insulin Market Revenue (USD billion) Forecast, By Region, 2018–2029

Table 07: North America Human Insulin Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 08: North America Human Insulin Market Revenue (USD billion) Forecast, By Analogue Insulin, 2018–2029

Table 09: North America Human Insulin Market Revenue (USD billion) Forecast, By Traditional Human Insulin, 2018–2029

Table 10: North America Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 11: North America Human Insulin Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 12: North America Human Insulin Market Revenue (USD billion) Forecast, By Country, 2018–2029

Table 13: U.S. Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 14: Canada Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 15: North America Human Insulin Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 16: North America Human Insulin Market Revenue (USD billion) Forecast, By Analogue Insulin, 2018–2029

Table 17: North America Human Insulin Market Revenue (USD billion) Forecast, By Traditional Human Insulin, 2018–2029

Table 18: Europe Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 19: Europe Human Insulin Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 20: Europe Human Insulin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018–2029

Table 21: U.K. Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 22: Germany Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 23: France Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 24: Italy Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 25: Spain Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 26: Scandinavia Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 27: Rest of Europe Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 28: Asia Pacific Human Insulin Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 29: Asia Pacific Human Insulin Market Revenue (USD billion) Forecast, By Analogue Insulin, 2018–2029

Table 30: Asia Pacific Human Insulin Market Revenue (USD billion) Forecast, By Traditional Human Insulin, 2018–2029

Table 31: Asia Pacific Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 32: Asia Pacific Human Insulin Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 33: Asia Pacific Human Insulin Market Revenue (USD billion) Forecast, By Country, 2018–2029

Table 34: China Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 35: Japan Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 36: India Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 37: Australia Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 38: Southeast Asia Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 39: Rest of Asia Pacific Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 40: Latin America Human Insulin Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 41: Latin America Human Insulin Market Revenue (USD billion) Forecast, By Analogue Insulin, 2018–2029

Table 42: Latin America Human Insulin Market Revenue (USD billion) Forecast, By Traditional Human Insulin, 2018–2029

Table 43: Latin America Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 44: Latin America Human Insulin Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 45: Latin America Human Insulin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018–2029

Table 46: Brazil Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 47: Mexico Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 48: Rest of Latin America Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 49: Middle East and Africa Human Insulin Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 50: Middle East and Africa Human Insulin Market Revenue (USD billion) Forecast, By Analogue Insulin, 2018–2029

Table 51: Middle East and Africa Human Insulin Market Revenue (USD billion) Forecast, By Traditional Human Insulin, 2018–2029

Table 52: Middle East and Africa Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 53: Middle East and Africa Human Insulin Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 54: Middle East and Africa Human Insulin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018–2029

Table 55: GCC Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 56: South Africa Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

Table 57: Rest of Middle East & Africa Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2018–2029

  • Nov, 2022
  • 2021
  • 2018-2020
  • 174

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X